Iron increases the susceptibility of multiple myeloma cells to bortezomib

Multiple myeloma is a malignant still incurable plasma cell disorder. Pharmacological treatment based on proteasome inhibition has improved patient outcome; however, bortezomib-resistance remains a major clinical problem. Inhibition of proteasome functionality affects cellular iron homeostasis and i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Campanella, Alessandro, Santambrogio, Paolo, Fontana, Francesca, Frenquelli, Michela, Cenci, Simone, Marcatti, Magda, Sitia, Roberto, Tonon, Giovanni, Camaschella, Clara
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669455/
https://ncbi.nlm.nih.gov/pubmed/23242599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.074872
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados